Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors

Background: Brain metastases and primary high-grade gliomas, including glioblastomas multiforme (GBM) and anaplastic astrocytomas (AA), may be indistinguishable by conventional magnetic resonance (MR) imaging. Identification of these tumors may have therapeutic consequences. Purpose: To assess the value of MR spectroscopy (MRS) using short and intermediate echo time (TE) in differentiating solitary brain metastases and high-grade gliomas on the basis of differences in metabolite ratios in the intratumoral and peritumoral region. Material and Methods: We performed MR imaging and MRS in 73 patients with histologically verified intraaxial brain tumors: 53 patients with high-grade gliomas (34 GBM and 19 AA) and 20 patients with metastatic brain tumors. The metabolite ratios of Cho/Cr, Cho/NAA, and NAA/Cr at intermediate TE and the presence of lipids at short TE were assessed from spectral maps in the tumoral core, peritumoral edema, and contralateral normal-appearing white matter. The differences in the metabolite ratios between high-grade gliomas/GBM/AA and metastases were analyzed statistically. Cutoff values of Cho/Cr, Cho/NAA, and NAA/Cr ratios in the peritumoral edema, as well as Cho/Cr and NAA/Cr ratios in the tumoral core for distinguishing high-grade gliomas/GBM/AA from metastases were determined by receiver operating characteristic (ROC) curve analysis. Results: Significant differences were noted in the peritumoral Cho/Cr, Cho/NAA, and NAA/ Cr ratios between high-grade gliomas/GBM/AA and metastases. ROC analysis demonstrated a cutoff value of 1.24 for peritumoral Cho/Cr ratio to provide sensitivity, specificity, positive (PPV), and negative predictive values (NPV) of 100%, 88.9%, 80.0%, and 100%, respectively, for discrimination between high-grade gliomas and metastases. By using a cutoff value of 1.11 for peritumoral Cho/NAA ratio, the sensitivity was 100%, the specificity was 91.1%, the PPV was 83.3%, and the NPV was 100%. Conclusion: The results of this study demonstrate that MRS can differentiate high-grade gliomas from metastases, especially with peritumoral measurements, supporting the hypothesis that MRS can detect infiltration of tumor cells in the peritumoral edema.

[1]  B A Kall,et al.  Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. , 1987, Mayo Clinic proceedings.

[2]  L. Deangelis,et al.  High‐grade gliomas in patients with prior systemic malignancies , 2002, Cancer.

[3]  S. Nelson.  Multivoxel magnetic resonance spectroscopy of brain tumors. , 2003, Molecular cancer therapeutics.

[4]  M. Law.  MR Spectroscopy of Brain Tumors , 2004, Topics in magnetic resonance imaging : TMRI.

[5]  E. Maiorano,et al.  Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues. , 1997, Ultrastructural pathology.

[6]  R. Lenkinski,et al.  A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. , 2006, AJNR. American journal of neuroradiology.

[7]  S. Shibata,et al.  [Ultrastructure of capillary permeability in human brain tumors. Part 1: Gliomas associated with cerebral edema (low density area)]. , 1985, No shinkei geka. Neurological surgery.

[8]  [Ultrastructure of capillary permeability in human brain tumor--Part 6: Metastatic brain tumor with brain edema]. , 1988, No shinkei geka. Neurological surgery.

[9]  D. Long,et al.  Capillary ultrastructure in human metastatic brain tumors. , 1979, Journal of neurosurgery.

[10]  S. Nelson.  Multivoxel magnetic resonance spectroscopy of brain tumors. , 2003, Molecular cancer therapeutics.

[11]  Robert J Young,et al.  Neuroimaging of metastatic brain disease. , 2005, Neurosurgery.

[12]  M Leonardi,et al.  Metabolic Findings on 3T 1H-MR Spectroscopy in Peritumoral Brain Edema , 2007, American Journal of Neuroradiology.

[13]  T. Bathen,et al.  Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T , 2007, BMC Cancer.

[14]  Christopher Nimsky,et al.  Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. , 2006, Radiology.

[15]  Glyn Johnson,et al.  High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. , 2002, Radiology.

[16]  Bruno Alfano,et al.  1H MR Spectroscopy in Patients with Metastatic Brain Tumors: A Multicenter Study , 1995, Magnetic resonance in medicine.

[17]  Kintomo Takakura,et al.  Proton MRS of the peritumoral brain , 2005, Journal of the Neurological Sciences.

[18]  Walter Stummer,et al.  Mechanisms of tumor-related brain edema. , 2007, Neurosurgical focus.

[19]  Scott W. Atlas,et al.  Magnetic Resonance Imaging of the Brain and Spine , 1991 .

[20]  Frederik L. Giesel,et al.  Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors , 2006, Neurology.

[21]  M. Berger,et al.  Differentiation of Glioblastoma Multiforme and Single Brain Metastasis by Peak Height and Percentage of Signal Intensity Recovery Derived from Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging , 2007, American Journal of Neuroradiology.

[22]  F. Howe,et al.  Differentiation of metastases from high‐grade gliomas using short echo time 1H spectroscopy , 2004, Journal of magnetic resonance imaging : JMRI.

[23]  J E Heiserman,et al.  Effect of voxel position on single-voxel MR spectroscopy findings. , 2000, AJNR. American journal of neuroradiology.

[24]  Webster K. Cavenee,et al.  The WHO Classification of Tumors of the Nervous System , 2002 .

[25]  Soonmee Cha,et al.  Perfusion MR Imaging of Brain Tumors , 2004, Topics in magnetic resonance imaging : TMRI.

[26]  W. Wick,et al.  Brain Edema in Neurooncology: Radiological Assessment and Management , 2004, Oncology Research and Treatment.

[27]  Y. Olsson,et al.  Hematogenous metastases of the human brain – Characteristics of peritumoral brain changes: A review , 1997, Journal of Neuro-Oncology.

[28]  R. Barnard,et al.  The incidence of multifocal cerebral gliomas. A histologic study of large hemisphere sections , 1987, Cancer.

[29]  M. Westphal,et al.  Cost of migration: invasion of malignant gliomas and implications for treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  F Ståhlberg,et al.  Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. , 2000, AJNR. American journal of neuroradiology.

[31]  C. Daumas-Duport,et al.  Serial stereotactic biopsies and CT scan in gliomas: correlative study in 100 astrocytomas, oligo-astrocytomas and oligodendrocytomas , 2004, Journal of Neuro-Oncology.

[32]  ChiangIC,et al.  Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings , 2004 .

[33]  M P Lichy,et al.  Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors , 2006, Neurology.

[34]  F. Yamasaki,et al.  Detection and differentiation of lactate and lipids by single-voxel proton MR spectroscopy , 2005, Neurosurgical Review.

[35]  Makoto Ochi,et al.  Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy , 2001, European Radiology.